ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 35 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 35 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 35 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 35 | -75.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 140 | -86.0% | 0.00% | – |
| Q4 2021 | $5,000 | -37.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $27,939,000 | 39.70% |
| RA Capital Management | 5,014,687 | $12,637,000 | 0.34% |
| Artal Group S.A. | 2,255,375 | $5,684,000 | 0.30% |
| Redmile Group, LLC | 1,608,089 | $4,052,000 | 0.16% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 242,978 | $612,000 | 0.15% |
| Orbimed Advisors | 1,584,845 | $3,994,000 | 0.07% |
| Baker Brothers Advisors | 2,591,366 | $6,530,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,776,744 | $4,477,000 | 0.02% |
| Woodline Partners LP | 233,180 | $588,000 | 0.01% |
| AXA S.A. | 567,310 | $1,429,811 | 0.00% |